We are live on ! Find out more

948 hedge funds and large institutions have $23.7B invested in Labcorp in 2021 Q2 according to their latest regulatory filings, with 102 funds opening new positions, 326 increasing their positions, 333 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed

637% more call options, than puts

Call options by funds: $440M | Put options by funds: $59.6M

55% more first-time investments, than exits

New positions opened: 102 | Existing positions closed: 66

6% more capital invested

Capital invested by funds: $22.5B → $23.7B (+$1.28B)

3% more funds holding

Funds holding: 920948 (+28)

2% less repeat investments, than reductions

Existing positions increased: 326 | Existing positions reduced: 333

2.44% less ownership

Funds ownership: 105.45%103% (-2.4%)

3% less funds holding in top 10

Funds holding in top 10: 3332 (-1)

Holders
948
Holders Change
+28
Holders Change %
+3.04%
% of All Funds
16.5%
Holding in Top 10
32
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-3.03%
% of All Funds
0.56%
New
102
Increased
326
Reduced
333
Closed
66
Calls
$440M
Puts
$59.6M
Net Calls
+$380M
Net Calls Change
+$305M

LH Hedge Fund Activity: Q2 2021 in Review

948 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Labcorp (LH) for Q2 2021, worth a combined $23.7B — up 5.7% from $22.5B a quarter earlier.

Buyers outnumbered sellers: 102 funds opened new LH positions and 66 closed out — a net gain of 36 holders — while 326 added to existing stakes and 333 trimmed.

The largest buyer was Melvin Capital Management, adding an estimated $119M. The largest seller was Allen Investment Management, cutting an estimated $306M.

  • 948 institutional investors held Labcorp (LH) as of Q2 2021, up from 920 in Q1 2021.
  • Funds reported $23.7B of Labcorp stock for Q2 2021, up 5.7% quarter-over-quarter.
  • 102 funds opened new Labcorp positions in Q2 2021 and 66 closed out, a net change of +36 holders.
  • The largest Labcorp buyer in Q2 2021 was Melvin Capital Management, an estimated $119M added.
  • The largest Labcorp seller in Q2 2021 was Allen Investment Management, an estimated $306M sold.

Based on aggregated 13F filings for Q2 2021.